SCHEMBL524010

SCHEMBL524010

NC[C@H]1CNC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL87711 1.00
SCHEMBL523957 1.00
Hydrochloric Acid SCHEMBL31624810 0.98
SCHEMBL9067713 0.83
SCHEMBL12564801 0.81 ALDH1A1 (0.50)
SCHEMBL2033238 0.80
SCHEMBL4578719 0.79
SCHEMBL7356952 0.77
SCHEMBL1098287 0.77
SCHEMBL7793918 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110172060-A Razaxaban, synthesis and refining methd 苏州二叶制药有限公司 2019-08-27 CN claimed
CN-106008491-B A kind of preparation method of razaxaban 苏州汇和药业有限公司 2019-04-05 CN claimed
CN-106008491-A Preparation method of Rivaroxaban 苏州汇和药业有限公司 2016-10-12 CN claimed
US-11040048-B2 Medicament for treating influenza characterized by combining a Cap-dependent endonuclease inhibitor and an anti-influenza drug SHIONOGI & CO., LTD. (JP) 2021-06-22 US disclosed
US-20200261481-A1 A MEDICAMENT FOR TREATING INFLUENZA CHARACTERIZED BY COMBINING A CAP-DEPENDENT ENDONUCLEASE INHIBITOR AND AN ANTI-INFLUENZA DRUG SHIONOGI & CO., LTD. (JP) 2020-08-20 US disclosed
CN-106008491-B A kind of preparation method of razaxaban 苏州汇和药业有限公司 2019-04-05 CN disclosed
CN-106008491-B A kind of preparation method of razaxaban 苏州汇和药业有限公司 2019-04-05 CN disclosed
CN-106008491-A Preparation method of Rivaroxaban 苏州汇和药业有限公司 2016-10-12 CN disclosed
CN-106008491-A Preparation method of Rivaroxaban 苏州汇和药业有限公司 2016-10-12 CN disclosed
US-9187478-B2 Substituted naphthyridines and their use as medicaments Boehringer Ingellheim International GmbH (DE) 2015-11-17 US disclosed
US-9187478-B2 Substituted naphthyridines and their use as medicaments Boehringer Ingellheim International GmbH (DE) 2015-11-17 US disclosed
WO-2005070891-A2 COMPOUNDS AND METHODS OF USE AMGEN INC (US) 2005-08-04 WO disclosed
US-20050143376-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones GORDEEV MIKHAIL F (US) 2005-06-30 US disclosed
US-6884813-B2 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA & UPJOHN COMPANY (US) 2005-04-26 US disclosed
US-6743811-B2 MICROBIOCIDES PHARMACIA & UPJOHN COMPANY 2004-06-01 US disclosed
US-20030232812-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA & UPJOHN COMPANY 2003-12-18 US disclosed
US-20020169191-A1 Oxazolidinone compounds and methods of preparation and use thereof PHARMACIA & UPJOHN COMPANY (US) 2002-11-14 US disclosed
US-6441005-B1 BACTERICIDES, ANTIBIOTICS AND MICROBIOCIDES PHARMACIA & UPJOHN COMPANY 2002-08-27 US disclosed
EP-1200416-A1 OXAZOLIDINONES AND THEIR USE AS ANTIINFECTIVES Pharmacia &amp; Upjohn Company (US) 2002-05-02 EP disclosed
WO-2001009107-A1 OXAZOLIDINONES AND THEIR USE AS ANTIINFECTIVES PHARMACIA & UPJOHN COMPANY (US) 2001-02-08 WO disclosed